Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law BPC 157: Experimental Peptide Creates Risk for Athletes In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few FDA Moves to Reevaluate Several Peptides American Med Spa Association Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law